Uniphar (DUB:UPR) Other Current Liabilities: €191 Mil (As of Dec. 2025)


DUB:UPR Uniphar PLC DUB:UPR
81 GF Score
Price €4.82
GF Value €3.64
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Uniphar Other Current Liabilities?

Uniphar DUB:UPR +0.42% 81 Other Current Liabilities is €191 Mil as of Dec. 2025. GuruFocus rates DUB:UPR with a GF Score™ of 81/100 and a GF Value™ of €3.64 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Uniphar's other current liabilities for the quarter that ended in Dec. 2025 was €191 Mil.

Uniphar's quarterly other current liabilities declined from Dec. 2024 (€202 Mil) to Jun. 2025 (€32 Mil) but then increased from Jun. 2025 (€32 Mil) to Dec. 2025 (€191 Mil).

Uniphar's annual other current liabilities declined from Dec. 2023 (€210 Mil) to Dec. 2024 (€202 Mil) and declined from Dec. 2024 (€202 Mil) to Dec. 2025 (€191 Mil).

Uniphar Other Current Liabilities Related Terms

Uniphar Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Uniphar's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar Other Current Liabilities Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 151.25 198.48 209.63 201.83 191.12

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 209.63 40.79 201.83 32.30 191.12
DUB:UPR
81GF Score
Uniphar PLC DUB:UPR
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uniphar Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €191 Mil mean?
Uniphar (DUB:UPR) has a Other Current Liabilities of €191 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Uniphar.
Is Uniphar's Other Current Liabilities too high?
Uniphar's current Other Current Liabilities is €191 Mil. Overall, Uniphar has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Other Current Liabilities compare to MCK and CAH?
Uniphar's Other Current Liabilities of €191 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Distribution company?
A good Other Current Liabilities depends on the Medical Distribution industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Uniphar. Uniphar's current Other Current Liabilities is €191 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (DUB:UPR) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.64, compared to a current price of €4.82 — trading 32.4% above its estimated fair value. The current Other Current Liabilities is €191 Mil. Uniphar's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Uniphar (DUB:UPR), the current Other Current Liabilities is €191 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (DUB:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of €4.82 is trading 32.4% above its estimated GF Value™ of €3.64. GuruFocus considers Uniphar to be Significantly Overvalued.

Key valuation signals for DUB:UPR:

  • Other Current Liabilities: €191 Mil
  • GF Value™: €3.64 vs. price of €4.82 (32.4% above fair value)
  • GF Score™: 81/100 with 9 warning signs

No single metric tells the full story. See the DUB:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Uniphar Business Description

Other Exchanges UPR:UK0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
81GF Score

Get the complete analysis for DUB:UPR

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.82
Price
€3.64
GF Value